Takeda has opened an expansion to its Jeddah, Saudi Arabia office. The move is part of Takeda's growing commitment to Saudi Arabia and the GCC. The company plans to launch additional products within the region in the near future.

The Jeddah office is Takeda's second in the country, with the first in Riyadh. Takeda's efforts to expand its operations within the country are likely part of a strategy to tap into the growing demand for medicines for non-communicable diseases, most notably type 2 diabetes. The office may also serve as a gateway to other Gulf countries.